Skip to main content
9 March 2021
Last updated:
Monday 8 March 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us

Research Directory

  • The Case for HTA co-operation

    Monday 12 May 2014
    Interviewee/Contributor
    Richard C. Ascroft et al
    Organisation
    Eli Lilly and Company
    Policy & Regulation
    Heath Technology Assessment (HTA)
    • Read more about The Case for HTA co-operation
  • Virtual drug development at Eli Lilly

    Monday 30 May 2011
    Interviewee/Contributor
    Aaron Schacht
    Organisation
    Eli Lilly and Company
    Strategy
    • Read more about Virtual drug development at Eli Lilly

Organisations

  • MedNous
  • Lead Pharma BV
  • London Genetics Ltd
  • Karus Therapeutics Ltd
  • Odlander, Fredrikson and Co AB
  • Cytograft Tissue Engineering Inc
  • Independent healthcare analyst
  • Medherant Ltd
  • CancerPartnersUK
  • Harvard Stem Cell Institute

Interviewees and Contributers

  • Paul Kemp
  • Jennifer Schneider
  • Bernd Hentsch et al
  • Tim Sturgeon and Martin Gouldstone
  • Philippe Villain-Guillot
  • Tony Woodgate
  • Donald Light
  • Stephan Christgau
  • Leonard Sacks
  • Chris Mayo

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Microbiotica expands management team
Wednesday February 10 2021
Philippe Dro joins Scenic Biotech as independent chairman
Wednesday February 10 2021
NOXXON announces senior appointment to its new advisory board
Wednesday February 10 2021
Wendy Levin joins Biofidelity as chief medical officer
Wednesday February 10 2021
VarmX appoints Gerard Short as chief medical officer
Wednesday February 10 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.